title: Can lymphoscintigraphy and gamma probe method in sentinel node biopsy for differentiated thyroid carcinoma obviate the disadvantages of the blue-dye method?
authors.forename: N
authors.initials: N
authors.lastname: Peparini
authors.forename: F M
authors.initials: FM
authors.lastname: Di Matteo
authors.forename: F
authors.initials: F
authors.lastname: Tartaglia
authors.forename: A
authors.initials: A
authors.lastname: Maturo
mesh_terms: D002277:Carcinoma / Q000473:pathology* / Q000556:secondary; D004396:Coloring Agents; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging; D008207:Lymphatic Metastasis / Q000175:diagnosis / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D021701:Sentinel Lymph Node Biopsy; D013668:Technetium Tc 99m Aggregated Albumin; D013964:Thyroid Neoplasms / Q000473:pathology*
chemical_list: D004396:Coloring Agents; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; C083602:technetium Tc 99m nanocolloid